$11.23
0.110.99%
At close: Aug 27, 5:00 PM EST
$11.23
N/A
After Hours: 4:00 PM EST
Keros Therapeutics Inc
KROSNASDAQ
Keros Therapeutics Earnings & Forecasts
Keros Therapeutics (KROS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Keros Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.24 | $-0.92 | $-0.47 | $-1.00 |
| Actual | $-1.45 | $-1.21 | $-0.86 | $-0.18 |
| Surprise | -16.9% | -31.5% | -83.0% | +82.0% |
| Revenue | ||||
| Estimate | $635000 | $2.4M | $4.8M | $5.6M |
| Actual | $0 | $367000 | $385000 | $14.3M |
| Surprise | -100.0% | -84.7% | -92.0% | +154.6% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.90 | $-1.77 | $-2.10 | $-2.21 |
| Revenue | ||||
| Consensus | $13.8M | $452856 | — | — |
